Growth Metrics

Bristol Myers Squibb (BMYMP) FCF Payout Ratio (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed FCF Payout Ratio for 17 consecutive years, with 0.79 as the latest value for Q4 2025.

  • Quarterly FCF Payout Ratio rose 162.33% to 0.79 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.39 through Dec 2025, up 12.6% year-over-year, with the annual reading at 0.39 for FY2025, 12.6% up from the prior year.
  • FCF Payout Ratio for Q4 2025 was 0.79 at Bristol Myers Squibb, up from 0.21 in the prior quarter.
  • The five-year high for FCF Payout Ratio was 0.79 in Q4 2025, with the low at 0.0 in Q2 2021.
  • Average FCF Payout Ratio over 5 years is 0.37, with a median of 0.32 recorded in 2021.
  • The sharpest move saw FCF Payout Ratio plummeted 98.8% in 2021, then soared 12086.9% in 2023.
  • Over 5 years, FCF Payout Ratio stood at 0.29 in 2021, then skyrocketed by 31.53% to 0.39 in 2022, then decreased by 23.54% to 0.3 in 2023, then rose by 1.41% to 0.3 in 2024, then soared by 162.33% to 0.79 in 2025.
  • According to Business Quant data, FCF Payout Ratio over the past three periods came in at 0.79, 0.21, and 0.35 for Q4 2025, Q3 2025, and Q2 2025 respectively.